---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-017343"
form_type: "8-K"
ticker: "CNTN"
cik: "0001861657"
company_name: "Canton Strategic Holdings, Inc."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T01:37:53.840718+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Hillstream BioPharma appoints Kelly Anderson to board, audit committee chair

## Summary
- Kelly Anderson appointed to Board effective May 9, 2023, replacing Leonard Mazur as audit committee chair.
- Also joins compensation and nominating/governance committees; board size increased to five.
- Over 25 years of public company finance/accounting experience; currently CEO of CXO Executive Solutions.
- Previously senior finance roles at Mavenlink, Ener-Core, Fisker Automotive, and other firms; CPA in California.
- Appointment fills vacancy created by board size increase; term expires at 2023 annual meeting.

## SEC filing metadata
- accession: 0001493152-23-017343
- form_type: 8-K
- ticker: CNTN
- cik: 0001861657
- company_name: Canton Strategic Holdings, Inc.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861657/000149315223017343/0001493152-23-017343-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861657/000149315223017343/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-017343
- JSON: https://secwatch.observer/filing/0001493152-23-017343.json
- Plain text: https://secwatch.observer/filing/0001493152-23-017343.txt

## Key facts
- Executive change
  Kelly Anderson was appointed as Director at Canton Strategic Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: On May 9, 2023, the Board of Directors (the “Board”) of Hillstream BioPharma, Inc. (the “Company”) increased the size of the Board to five members and appointed Kelly Anderson as a member of the Board to fill the vacancy created by the increase in the size of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861657/000149315223017343/0001493152-23-017343-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.